Heterocyclic compounds capable of activating STING

Tetrahydronaphthalene and tetrahydroisoquinoline derivatives as estrogen receptor degraders

TRK inhibitors useful as anticancer drugs

CRYSTALLINE FORMS OF A BIPHENYL COMPOUND

LIVER X RECEPTOR (LXR) MODULATORS

ISOTHIOCYANATE FUNCTIONAL SURFACTANTS, FORMULATIONS INCORPORATING THE SAME, AND ASSOCIATED METHODS OF USE

METHODS OF TREATING HER2 POSITIVE BREAST CANCER WITH TUCATINIB IN COMBINATION WITH AN ANTI-HER2 ANTIBODY-DRUG CONJUGATE

Compositions and methods for transport across the blood brain barrier

ADRENOMEDULLIN-ANALOGUES FOR LONG-TERM STABILIZATION AND THEIR USE

METHOD OF PREVENTING ADVERSE EFFECTS BY GLP-1

TRANS CAROTENOIDS, THEIR SYNTHESIS, FORMULATION AND USES

HUMANIZED ANTI-CD40 ANTIBODIES AND USES THEREOF

BISPECIFIC ANTIBODIES SPECIFICALLY BINDING TO PD1 AND LAG3

COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY

METHODS OF MAKING CELLULAR THERAPIES

METHODS OF MODULATING IMMUNE ACTIVITY

CANCER VACCINE

TREATMENT OF MODERATE TO SEVERE INFLUENZA

Treatment of submental fat

PROSTACYCLIN ANALOGUE FORMULATIONS

TARGETING THE NEUROLIGIN-3 BINDING PARTNER CSPG4 IN GLIOMA

1,4-DISUBSTITUTED PYRIDAZINE ANALOGS THERE OF AND METHODS FOR TREATING SMN-DEFICIENCY-RELATED CONDITIONS

Apixaban film product and uses thereof

ANTIPROLIFERATIVE COMPOUNDS AND METHODS OF USE THEREOF

COMBINATIONS COMPRISING BENZODIOXOL AS GLP-1R AGONISTS FOR USE IN THE TREATMENT OF NASH/NAFLD AND RELATED DISEASES

COMPOUNDS AND COMPOSITIONS FOR TREATING CONDITIONS ASSOCIATED WITH NLRP ACTIVITY

METHODS OF TREATING CANCER USING ANDROGEN RECEPTOR ANTAGONISTS

TREATMENTS FOR CHARCOT-MARIE-TOOTH DISEASE

MULTICYCLIC COMPOUNDS AND METHODS OF USE THEREOF

AQUEOUS IRON CARBOHYDRATE COMPLEXES, THEIR PRODUCTION AND MEDICAMENTS CONTAINING THEM

TUCARESOL DERIVATIVES AND USES THEREOF

COMPOSITIONS COMPRISING A DHODH INHIBITOR FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA

SYNERGISTIC INHIBITORS OF CREB-MEDIATED GENE TRANSCRIPTION

EXTENDED RELEASE PHARMACEUTICAL FORMULATION

Method and composition for selective treatment of androgen receptors

Use of cannabinoids in the treatment of epilepsy

Pharmaceutical composition comprising the phytocannabinoids cannabidivarin (CBDV) and cannabidiol (CBD)

Compositions and methods comprising deoxy-pentitols

Transdermal drug delivery system

Method for producing a drug delivery system

Method for producing a drug delivery system

Method for producing a drug delivery system

METHOD FOR MANUFACTURING DISPERSION OF ULTRAFINE PARTICLES OF POORLY SOLUBLE SUBSTANCE

FORMULATION

Pharmaceutical ophthalmic compositions

METHOD OF TREATING DISEASE

COMPOSITION AND METHOD FOR TREATMENT OF DIABETES

METHOD FOR REDUCING THE EXPRESSION OF NKCC1 IN A SUBJECT

Organic compositions to treat HSF1-related diseases

RNA interference mediated inhibition of prolyl hydroxylase domain 2 (PHD2) gene expression using short interfering nucleic acid (siNA)

METHODS AND COMPOSITIONS FOR TREATMENT OF POLYCYSTIC KIDNEY DISEASE

ORAL DELIVERY OF OLIGONUCLEOTIDES

ANTI-OX40 ANTIBODIES, ANTI-GITR ANTIBODIES, AND METHODS OF USE THEREOF

ANTI-CD154 ANTIBODIES AND USES THEREOF

COMBINATION THERAPIES TARGETING PD-1, TIM-3, AND LAG-3

COMPOUNDS AND METHODS FOR TREATING CANCER, VIRAL INFECTIONS, AND ALLERGIC CONDITIONS

NEUROPROTECTIVE PDI MODULATING SMALL MOLECULES AND METHODS OF USE THEREOF

NEW MACROCYCLIC COMPOUNDS AND DERIVATIVES AS EGFR INHIBITORS

MLL1 INHIBITORS AND ANTI-CANCER AGENTS

MODIFIED CARBAZOLES AS THERAPEUTIC AGENTS

CROSSLINKED OPTICALLY ACTIVE SECONDARY AMINE DERIVATIVE

Tetrahydro-benzoazepine glycosidase inhibitors

Splicing modulator antibody-drug conjugates and methods of use

INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF

2,3-DIHYDRO-ISOINDOLE-1-ON DERIVATIVE AS BTK KINASE SUPPRESSANT, AND PHARMACEUTICAL COMPOSITION INCLUDING SAME

INHIBITORS OF HIV-1 NEF FOR THE TREATMENT OF HIV DISEASE

PHARMACEUTICAL COMPOSITION FOR TREATING OR PREVENTING MIDDLE EAST RESPIRATORY SYNDROME

COMPOUNDS HAVING ANTIMALARIAL ACTIVITY

TRANSMEMBRANE PORES FORMED BY AROMATIC OLIGOAMIDE FOLDAMERS AND USES OF SAME

Specific conjugation linkers, specific immunoconjugates thereof, methods of making and uses such conjugates thereof

INSULIN ANALOGS AND METHODS OF USING THE SAME

Cannabinoid Conjugate Molecules

Compositions, methods and kits for eliciting an immune response

TREATMENT OF CLOSTRIDIUM DIFFICILE INFECTIONS

Treatment Involving Therapeutic Antibody and Interleukin-2 (IL2)

RECEPTOR-BASED ANTAGONISTS OF THE PROGRAMMED CELL DEATH 1 (PD-1) PATHWAY

Methods of using OX40 ligand encoding polynucleotides

Formulation for and Method of Using an Herbal Tea for the Treatment of Urinary Tract Infections

COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, ENHANCING DRUG POTENCY AND TREATING CANCER, AND METHODS FOR MAKING AND USING SAME

C. NOVYI FOR THE TREATMENT OF SOLID TUMORS IN HUMANS

3-substituted piperidine compounds for Cbl-b inhibition, and use thereof

COMPOSITIONS AND METHODS FOR PROMOTING HEMATOPOIETIC CELL CYTOTOXICITY

SYNTHETIC RIG-I-LIKE RECEPTOR AGONISTS

2-BENZYLIDENE HYDRAZINOADENOSINE COMPOUNDS HAVING A2A ADENOSINE RECEPTOR AGONISTIC ACTIVITY

SPINOSYN FORMULATIONS FOR TREATMENT OF DEMODEX-INDUCED OCULAR AND FACIAL CONDITIONS

NOVEL COMPOUNDS

DPP-IV INHIBITOR COMBINED WITH A FURTHER ANTIDIABETIC AGENT, TABLETS COMPRISING SUCH FORMULATIONS, THEIR USE AND PROCESS FOR THEIR PREPARATION

TREATING COGNITIVE DISORDERS USING TRAPIDIL

JAK1 INHIBITORS FOR THE TREATMENT OF MYELODYSPLASTIC SYNDROMES

MODULATING EXPRESSION LEVEL OF A GENE ENCODING A CYTOCHROME P450 PROTEIN BY TREATING A HUMAN SUBJECT WITH A NITROXIDE

4H-PYRROLO[3,2-C]PYRIDIN-4-ONE DERIVATIVES

Inhibitors of lysyl oxidases

ANTIBODY DRUG CONJUGATES COMPRISING STING AGONISTS

TOPICAL COMPOSITION FOR TREATING SKIN WOUNDS

COMPOSITIONS AND METHODS OF MAKING EXPANDED HEMATOPOIETIC STEM CELLS USING DERIVATIVES OF CARBAZOLE

TREATMENT OF METABOLIC DISORDERS IN CANINE ANIMALS

NEURODEGENERATIVE DISORDERS AND MUSCLE DISEASES IMPLICATING PUFAS

METHODS AND COMPOSITIONS FOR TREATING SLEEP APNEA

Use of cannabinoids in the treatment of epilepsy

Anti-FOLR1 Immunoconjugate Dosing Regimens

CONTINUOUS OR PERIODICAL TRANSDERMAL DELIVERY OF EXOGENOUS MOLECULE

TREATMENT OF PANCREATIC CANCER

Containers with selective dissolved gas content

Combination therapy intravaginal rings

COMPOSITIONS AND THEIR USE

COMPOSITION FOR DETERMINATION OF CELL-MEDIATED IMMUNE RESPONSIVENESS

Methods for diagnosing and treating inflammatory bowel disease

Modified antisense oligonucleotide for inhibition of FoxP3 expression

CHIMERIC ANTIGEN RECEPTORS (CARs) HAVING MUTATIONS IN THE FC SPACER REGION AND METHODS FOR THEIR USE

ANTI-CD39 ANTIBODIES, COMPOSITIONS COMPRISING ANTI-CD39 ANTIBODIES AND METHODS OF USING ANTI-CD39 ANTIBODIES

SYNERGISTIC COMBINATIONS OF OX40L ANTIBODIES FOR THE TREATMENT OF GVHD

ANTI-PD-1 ANTIBODIES AND METHODS OF USE THEREOF

METHODS FOR TREATING ANEMIA OF CHRONIC DISEASE

METHODS FOR TREATING MYELOFIBROSIS AND RELATED CONDITIONS

CLAUDIN6 ANTIBODIES AND METHODS OF TREATING CANCER

Anti CCL24 (eotaxin2) antibodies for use in the treatment of hepatic diseases

PDL1 peptides for use in cancer vaccines

NOVEL RECEPTORS HAVING A HETEROLOGOUS STOP TRANSFER SEQUENCE FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION

CERTAIN CHEMICAL ENTITIES, COMPOSITIONS AND METHODS

SMALL CATIONIC ORTHO-5,15-DI-HETEROARYL-PORPHYRINS DERIVATIVES AND THEIR APPLICATIONS IN PHOTOINACTIVATION OF MICROORGANISMS

Organic compounds

SUBSTITUTED PYRROLOPYRIDINES AS JAK INHIBITORS

Substituted pyrimidines and methods of use

Adaptive sheet caliper control system and apparatus and methods

ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICE

CHITOSAN-CONTAINING FORMULATIONS AND METHODS OF MAKING AND USING THE SAME

Polyglutamated antifolates and uses thereof

Compositions, Methods and Kits for Eliciting an Immune Response

COMPOSITIONS, METHODS AND USES FOR THERMALLY STABLE HUMAN PAPILLOMAVIRUS FORMULATIONS

Methods for treating, ameliorating or preventing infections using drug and vaccination combination treatment

METHODS AND COMPOSITIONS FOR TREATING CANCERS

VACCINE AND METHOD FOR TREATING CANCER

CEREBLON-BASED HETERODIMERIZABLE CHIMERIC ANTIGEN RECEPTORS

IL-10/fc Fusion Proteins Useful As Enhancers Of Immunotherapies

Method of Treatment

Calreticulin for Treating or Preventing an Angiogenic Eye Disease

PREBIOTIC-INDUCED ANTI-TUMOR IMMUNITY

ANTIVIRAL ESSENTIAL OIL COMPOSITIONS

AMMONIA OXIDIZING MICROORGANISMS FOR THE TREATMENT OF DIAPER RASH, ATHLETE?S FOOT, CONTACT DERMATITIS, PERSPIRATION, AND BODY ODOR

Microbial compositions for improving the efficacy of anticancer treatments based on immune checkpoint inhibitors and/or tyrosine kinase inhibitors and markers of responsiveness to such treatments

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING CROHN'S DISEASE

Treatment of inflammation with glucocorticoids and angiopoietin-like 7 (ANGPTL7) inhibitors

FUNGAL COMPOUND COMPOSITIONS AND METHODS FOR MODULATING INFLAMMATION

Methods of treating inflammation and/or pain

COMPOSITION AND METHOD FOR TREATMENT OF HIPPOCAMPAL SYNAPSE DYSFUNCTION AND COGNITIVE DEFICITS IN ALZHEIMER'S DISEASE

USING OF A PPAR-DELTA AGONIST IN THE TREATMENT OF KIDNEY DISEASE

Salts and Solid Form of a BTK Inhibitor

METHODS OF TREATMENT AND/OR PREVENTION OF MAJOR ADVERSE CARDIOVASCULAR EVENTS (MACE) WITH A COMBINATION OF A BET BROMODOMAIN INHIBITOR AND A SODIUM DEPENDENT GLUCOSE TRANSPORT 2 INHIBITOR

METHOD OF TREATING ALZHEIMER'S DISEASE

4-SUBSTITUTED PYRROLO[2,3-B]PYRIDINE AS ERBB MODULATORS USEFUL FOR TREATING CANCER

C-Met Modulator Pharmaceutical Compositions

METHODS AND COMPOSITIONS FOR TREATING CANCER

COMPOUNDS AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISORDERS

Tetrahydro-1H-pyrido [3,4-b]indole anti-estrogenic drugs

Spirocyclic 2,3-dihydro-7-azaindole compounds and uses thereof

COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF KRAS

Method and Composition for Increasing Muscle Protein Synthesis

COMBINATIONS OF MEK INHIBITORS WITH CAP-DEPENDENT ENDONUCLEASE INHIBITORS

METHODS AND COMPOSITIONS FOR CORRECTION OF AUTONOMIC DYSFUNCTIONS

SEQUENTIAL MULTI-STEP FLASH NANOPRECIPITATION FOR THE FORMATION OF NANOPARTICLES WITH HIGH CORE LOADINGS

GLUTAMINASE INHIBITOR DISCOVERY AND NANOPARTICLE-ENHANCED DELIVERY FOR CANCER THERAPY

LIPID NANOPARTICLES COMPRISING LIPOPHILIC ANTI-INFLAMMATORY AGENTS AND METHODS OF USE THEREOF

Gastro-Retentive Sustained-Release Oral Dosage Form of a Bile Acid Sequestrant

PROGRAMMABLE PHARMACEUTICAL COMPOSITIONS FOR CHRONO DRUG RELEASE

ORAL COMPOSITIONS AND RELATED METHODS FOR REDUCING THROAT IRRITATION

COMPOSITIONS AND METHODS FOR MEASURING AND INHIBITING CALPAIN-5 ACTIVITY

Modified Short Interfering Nucleic Acid (siNA) Molecules and Uses Thereof

COMPOSITIONS AND METHODS FOR REPROGRAMMING AGE-RESTRICTED NON-NEURONAL CELLS

METHODS FOR TREATING PROGRESSIVE MULTIPLE SCLEROSIS

METHODS OF TREATING PD-L1 EXPRESSING CANCER

METHODS FOR TREATING CORONAVIRUS INFECTION AND RESULTING INFLAMMATION-INDUCED LUNG INJURY

Signature of TL1A (TNFSF15) signaling pathway

Polyomavirus neutralizing antibodies

Prodrugs of 4′-C-substituted-2-halo-2′- deoxyadenosine nucleosides and methods of making and using the same

Novel Ferroportin Inhibitors

5-(Thiophen-2-YL)-1 H-Tetrazole Derivative as BCKDK Inhibitors Useful for Treating Various Diseases

Cocrystals, pharmaceutical compositions thereof, and methods of treatment involving same

Anti-inflammatory and antitumor 2-oxothiazoles and 2-oxothiophenes compounds

Selective histone deacetylase inhibitors for the treatment of human disease

ORGANIC COMPOUNDS

ANTIVIRAL COMPOUNDS

TREPROSTINIL DERIVATIVES AND COMPOSITIONS AND USES THEREOF

Pharmaceutical compositions comprising monoterpenes

METHODS FOR TREATING NEOPLASTIC CONDITIONS OF THE SKIN

SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS

LIQUID COMPOSITIONS COMPRISING A LEVODOPA AMINO ACID CONJUGATE AND USES THEREOF

USES FOR AND ARTICLE OF MANUFACTURE INCLUDING HER2 DIMERIZATION INHIBITOR PERTUZUMAB

Use of lysin to restore/augment antibacterial activity in the presence of pulmonary surfactant of antibiotics inhibited thereby

Methods for treating lysosomal acid lipase deficiency in patients

Compositions and methods for treating heart failure

SYSTEMS AND METHODS FOR PRODUCING A KAVA LIQUID DIETARY SUPPLEMENT

COMPOSITION FOR INHIBITING TUMOR PROLIFERATION COMPRISING SALVIA PLEBEIA EXTRACT AS EFFECTIVE COMPONENT

Altering the intestinal microbiome in cystic fibrosis

LMP-1 EXPRESSING CELLS AND METHODS OF USE THEREOF

Combined organ and hematopoietic cells for transplantation tolerance of grafts

Method and composition for preventing or treating diarrhea, constipation or irritable bowel syndrome with fibers formed of β-1-4-glucan

ALTERING MICROBIAL POPULATIONS & MODIFYING MICROBIOTA

COMBINATION PRODUCTS OF TOBRAMYCIN COMPOUNDS AND DEXAMETHASONE COMPOUNDS

Medicament for prevention or treatment of rhinovirus infection

ANTIMICROBIAL AND ANTIVIRAL EFFECTS OF C2-C7 ALKYL BORONIC ACIDS

Bicyclic heteroaryl derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors

TREATMENT FOR FIBROSIS AND INHIBITION OF FIBROSIS

THERAPEUTIC NANOPARTICLES FOR THE TREATMENT OF NEUROBLASTOMA AND OTHER CANCERS

DISRUPTION OF VASCULAR SMOOTH MUSCLE RELAXATION BY CARFILZOMIB MAY BE THE PRIMARY REASON FOR CFZ-INDUCED VASCULAR DYSFUNCTION

METHODS OF TREATING NON-HODGKIN LYMPHOMA USING 2-(2,6-DIOXOPIPERIDIN-3-YL)-4-((2-FLUORO-4-((3-MORPHOLINOAZETIDIN-1-YL)METHYL)BENZYL)AMINO)ISOINDOLINE-1,3-DIONE

Carboxamide-pyrimidine derivatives as SHP2 antagonists

NOVEL METHODS

METHODS FOR PREDICTING DRUG RESPONSIVENESS IN CANCER PATIENTS

BILE ACID RECYCLING INHIBITORS AND SATIOGENS FOR TREATMENT OF DIABETES, OBESITY, AND INFLAMMATORY GASTROINTESTINAL CONDITIONS

NOVEL METHODS OF TREATING A NEURODEGENERATIVE DISEASE IN A MAMMAL IN NEED THEREOF

Use of Hsp70 as a regulator of enzymatic activity

Methods and compositions for treatment of epileptic disorders

Uses of indolinone compounds

METHODS AND COMPOSITIONS FOR TREATING CHEMOTHERAPY-INDUCED DIARRHEA

AGENT FOR PROMOTING ODONTOBLAST PROPAGATION AND DIFFERENTIATION

COMPOSITIONS AND METHODS FOR TREATING MACROPHAGE ACTIVATION SYNDROME

Pharmaceutical compositions comprising levodopa, a dopamine decarboxylase inhibitor and a COMT inhibitor and method of administration thereof

PHARMACEUTICAL COMPOSITION FOR REDUCING LOCAL FAT AND USES THEREOF

ISOTRETINOIN FORMULATIONS AND USES AND METHODS THEREOF

Non-cellular root canal filler and non-cellular dental tissue regeneration promotion kit

Methods of Treatments Based Upon Molecular Characterization of Breast Cancer

CORRECTION OF EXON SKIPPING IN MONOCYTE-DERIVED CELLS FOR IMPROVED IMMUNE RESPONSE

SOLUBILIZED APYRASES, METHODS AND USE

NATRIURETIC PEPTIDE RECEPTOR 1 ANTIBODIES AND METHODS OF USE

Anti-SARS-CoV-2-spike glycoprotein antibodies and antigen-binding fragments

CYTOKINE PRODRUGS AND DUAL-PRODRUGS

Chimeric protein in the treatment of amyloidosis

Polypeptide integrin antagonists

FUSED 1,4-DIAZEPINES AS BET PROTEIN DEGRADERS

ABUSE-RESISTANT LONG-ACTING RELEASE OPIOID PRODRUGS

CGAS antagonist compounds

Hydrogel prodrug for treatment

Hydrogel prodrug for treatment

METHODS OF TREATING MYOINTIMAL PROLIFERATION

NOVEL COMPOSITIONS FOR DISRUPTING BIOFILMS

METHODS AND COMPOSITIONS OF NEUREGULINS FOR PREVENTING, TREATING OR DELAYING PRESERVED EJECTION FRACTION CARDIAC FAILURE

COMPOSITIONS FOR IMPROVED NRF2 ACTIVATION AND METHODS OF THEIR USE

TREATMENT OF TUMORS BY A COMBINATION OF AN ONCOLYTIC ADENOVIRUS, A CDK4/6 INHIBITOR AND A FURTHER THERAPEUTICALLY ACTIVE AGENT

Purified anthelmintic compositions and related methods

Cancer therapy

TREATMENT OF MYELOSUPPRESSION

METHODS FOR THE PREPARATION OF RIBOSIDES

Substituted quinazolines for inhibiting kinase activity

Therapeutically active compounds and their methods of use

Treatment of Conditions Associated With Decreased Folate in Cerebral Spinal Fluid

Methods and Compositions for Treating Thyroid-Related Medical Conditions with Reduced Folates

THIAMINE THERAPY FOR FATTY LIVER ASSOCIATED DISEASES

Pharmaceutical combinations comprising a histone deacetylase inhibitor and a CD38 inhibitor and methods of use thereof

TREATMENT AND PREVENTION OF OCULAR NEURODEGENERATIVE DISORDER

Method of treating C3 glomerulopathy

MOVEMENT DISORDERS

NTRANASAL DANTROLENE ADMINISTRATION FOR TREATMENT OF ALZHEIMER'S DISEASE

MDMA ENANTIOMERS

Antineoplastic Combinations with m-TOR Inhibitor, Trastuzumab and/or HKI-272

METHODS FOR TREATING BRAIN INJURY OR COGNITIVE DYSFUNCTION BY PHARMACOLOGICAL ENHANCMENT OF M-TYPE POTASSIUM ION CURRENTS IN NEURONS

Compositions comprising citrulline and leucine and their use in the treatment of diabetes and metabolic syndrome

METHODS AND COMPOSITIONS FOR MODULATING MACROPHAGES POLARIZATION

GLYCOLIC ACID PROTECTS AGAINST ISCHEMIC INSULTS

AQUEOUS PATCH

EXTENDED RELEASE PHARMACEUTICAL FORMULATION AND METHODS OF TREATMENT

FORMULATIONS OF 3-(6-(1-(2,2-DIFLUOROBENZO[D][1,3]DIOXOL-5-YL) CYCLOPROPANECARBOXAMIDO)-3-METHYLPYRIDIN-2-YL)BENZOIC ACID

REALIZING THE NANO-AMORPHOUS STATE OF MATERIALS INSIDE NANO-POROUS TEMPLATES

CA-IX APTAMERS AND DIAGNOSTIC AND THERAPEUTIC USES THEREOF

GENETICALLY MODIFIED NATURAL KILLER CELLS

CONFORMATION-SPECIFIC ANTIBODIES THAT BIND NUCLEAR FACTOR KAPPA-LIGHT-CHAIN-ENHANCER OF ACTIVATED B CELLS

NOVEL RECEPTORS HAVING A FIBRONECTIN REPEAT FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION

CHIMERIC NK RECEPTOR AND METHODS FOR TREATING CANCER

Benzoimidazole Derivatives As Anticancer Agents

Crystal forms of (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide

Pyrrolopyrimidine ITK inhibitors

Crystalline forms of diazabicyclooctane derivative and production process thereof

CXCR4 Receptor Antagonists

DIHYDROPYRIMIDINE DERIVATIVES AND USES THEREOF IN THE TREATMENT OF HBV INFECTION OR OF HBV-INDUCED DISEASES

Heteroaryl aminopropanol derivatives

Chemical compounds

SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASE

METHODS AND COMPOSITIONS FOR THE EXPRESSION OF CONSTITUTIVELY ACTIVE RAP1A FROM A VMD2 PROMOTER

SELECTIVE DELIVERY OF THERAPEUTIC AND IMAGING AGENTS

High load dispersions

QUORUM-SENSING INHIBITORS AND/OR POSTBIOTIC METABOLITES AND RELATED METHODS

Açai berry seed extract, fractions of açai berry seed extracts, process for obtaining açai berry seed extracts, pharmaceutical and food compositions and method for the treatment of diseases or disorders with açai berry seed extract

SYSTEMS AND METHODS FOR PRODUCING A KAVA LIQUID DIETARY SUPPLEMENT

ANTICANCER COMPOSITION COMPRISING TUMOR-SPECIFIC ONCOLYTIC ADENOVIRUS AND IMMUNE CHECKPOINT INHIBITOR

BACTERIAL COMPOSITIONS FOR THE TREATMENT OF DISEASE

AMMONIA OXIDIZING MICROORGANISMS FOR USE AND DELIVERY TO THE INTRANASAL SYSTEM

COMPOSITIONS FOR THE TREATMENT OF NEUROPATHIC PAIN AND SENSITIZATION OF TUMORS TO CHEMOTHERAPIES

Engraftment of stem cells with a combination of an agent that targets stem cells and modulation of immunoregulatory signaling

METHODS OF PROPHYLAXIS AND TREATMENT OF COVID-19 USING AZOXIMER BROMIDE

GENE DELIVERY SYSTEMS FOR TREATMENT OF HEART FAILURE

METHODS AND COMPOSITIONS FOR TREATING PAIN AND OTHER EPH RECEPTOR-ASSOCIATED CONDITIONS

TREATMENT COMPRISING FXR AGONISTS

PROMOTING TISSUE REGENERATION

RUXOLITINIB FOR THE TREATMENT OF PRURIGO NODULARIS

Phenyl-sulfamoyl.benzoyc acids as ERAP1 modulators

PYRIDAZINONE DERIVATIVE

METHODS OF TREATING LIVER FIBROSIS USING CALPAIN INHIBITORS

COMBINATION TREATMENTS

TREATMENT OF PRURIGO NODULARIS

Schizophrenic Disorder Treatment using Combination Therapy

SUSTAINED RELEASE PHARMACEUTICAL COMPOSITIONS COMPRISING (1R, 5S)-1-(NAPHTHALEN-2-YL)-3-AZABICYCLO[3.1.0]HEXANE